nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—Renal artery stenosis—Ramipril—type 1 diabetes mellitus	0.0617	0.152	CcSEcCtD
Pramipexole—HTR2A—arteriole—type 1 diabetes mellitus	0.0145	0.164	CbGeAlD
Pramipexole—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.0092	0.0227	CcSEcCtD
Pramipexole—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.00906	0.0223	CcSEcCtD
Pramipexole—DRD1—nerve—type 1 diabetes mellitus	0.00894	0.102	CbGeAlD
Pramipexole—Balance disorder—Ramipril—type 1 diabetes mellitus	0.00813	0.02	CcSEcCtD
Pramipexole—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.00765	0.0189	CcSEcCtD
Pramipexole—Psoriasis—Ramipril—type 1 diabetes mellitus	0.00707	0.0174	CcSEcCtD
Pramipexole—Parosmia—Ramipril—type 1 diabetes mellitus	0.00685	0.0169	CcSEcCtD
Pramipexole—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0064	0.0158	CcSEcCtD
Pramipexole—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00619	0.0704	CbGeAlD
Pramipexole—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.00595	0.0147	CcSEcCtD
Pramipexole—Ageusia—Ramipril—type 1 diabetes mellitus	0.00549	0.0135	CcSEcCtD
Pramipexole—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00536	0.0132	CcSEcCtD
Pramipexole—DRD2—nerve—type 1 diabetes mellitus	0.00528	0.06	CbGeAlD
Pramipexole—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00526	0.0597	CbGeAlD
Pramipexole—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00513	0.0127	CcSEcCtD
Pramipexole—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00506	0.0125	CcSEcCtD
Pramipexole—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00499	0.0123	CcSEcCtD
Pramipexole—Cough increased—Ramipril—type 1 diabetes mellitus	0.00486	0.012	CcSEcCtD
Pramipexole—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00473	0.0117	CcSEcCtD
Pramipexole—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00467	0.0115	CcSEcCtD
Pramipexole—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00447	0.0508	CbGeAlD
Pramipexole—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00432	0.0106	CcSEcCtD
Pramipexole—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00417	0.0103	CcSEcCtD
Pramipexole—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00404	0.00996	CcSEcCtD
Pramipexole—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00398	0.00981	CcSEcCtD
Pramipexole—SLC22A2—nephron tubule—type 1 diabetes mellitus	0.00391	0.0444	CbGeAlD
Pramipexole—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00373	0.00919	CcSEcCtD
Pramipexole—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00364	0.00898	CcSEcCtD
Pramipexole—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00361	0.00889	CcSEcCtD
Pramipexole—Deafness—Ramipril—type 1 diabetes mellitus	0.00361	0.00889	CcSEcCtD
Pramipexole—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00354	0.00873	CcSEcCtD
Pramipexole—HTR2A—nerve—type 1 diabetes mellitus	0.00348	0.0396	CbGeAlD
Pramipexole—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00348	0.00858	CcSEcCtD
Pramipexole—DRD5—lymphoid tissue—type 1 diabetes mellitus	0.00344	0.0392	CbGeAlD
Pramipexole—Amnesia—Ramipril—type 1 diabetes mellitus	0.00343	0.00847	CcSEcCtD
Pramipexole—SLC22A2—kidney—type 1 diabetes mellitus	0.00343	0.039	CbGeAlD
Pramipexole—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00341	0.0084	CcSEcCtD
Pramipexole—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00339	0.00836	CcSEcCtD
Pramipexole—Purpura—Ramipril—type 1 diabetes mellitus	0.00335	0.00826	CcSEcCtD
Pramipexole—Arthritis—Ramipril—type 1 diabetes mellitus	0.00332	0.00819	CcSEcCtD
Pramipexole—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00331	0.00815	CcSEcCtD
Pramipexole—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00331	0.00815	CcSEcCtD
Pramipexole—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00324	0.00799	CcSEcCtD
Pramipexole—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.0032	0.00789	CcSEcCtD
Pramipexole—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00295	0.00727	CcSEcCtD
Pramipexole—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00295	0.00727	CcSEcCtD
Pramipexole—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00292	0.00719	CcSEcCtD
Pramipexole—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00291	0.00716	CcSEcCtD
Pramipexole—Gastritis—Ramipril—type 1 diabetes mellitus	0.00286	0.00704	CcSEcCtD
Pramipexole—Asthma—Ramipril—type 1 diabetes mellitus	0.00279	0.00688	CcSEcCtD
Pramipexole—Influenza—Ramipril—type 1 diabetes mellitus	0.00279	0.00688	CcSEcCtD
Pramipexole—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00279	0.00688	CcSEcCtD
Pramipexole—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00273	0.00674	CcSEcCtD
Pramipexole—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00272	0.0067	CcSEcCtD
Pramipexole—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00268	0.00661	CcSEcCtD
Pramipexole—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00267	0.00659	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00259	0.00639	CcSEcCtD
Pramipexole—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00257	0.00633	CcSEcCtD
Pramipexole—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00255	0.00628	CcSEcCtD
Pramipexole—Weight increased—Ramipril—type 1 diabetes mellitus	0.00254	0.00626	CcSEcCtD
Pramipexole—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.00254	0.0288	CbGeAlD
Pramipexole—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.00246	0.0279	CbGeAlD
Pramipexole—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00245	0.00604	CcSEcCtD
Pramipexole—Renal failure—Ramipril—type 1 diabetes mellitus	0.00244	0.00603	CcSEcCtD
Pramipexole—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00244	0.00601	CcSEcCtD
Pramipexole—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00244	0.00601	CcSEcCtD
Pramipexole—SLC22A1—kidney—type 1 diabetes mellitus	0.00243	0.0276	CbGeAlD
Pramipexole—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00242	0.00596	CcSEcCtD
Pramipexole—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00242	0.00596	CcSEcCtD
Pramipexole—HTR1D—kidney—type 1 diabetes mellitus	0.0024	0.0273	CbGeAlD
Pramipexole—Sweating—Ramipril—type 1 diabetes mellitus	0.00238	0.00588	CcSEcCtD
Pramipexole—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00235	0.0058	CcSEcCtD
Pramipexole—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00235	0.00578	CcSEcCtD
Pramipexole—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00233	0.00575	CcSEcCtD
Pramipexole—HTR2B—cardiovascular system—type 1 diabetes mellitus	0.00229	0.026	CbGeAlD
Pramipexole—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.0022	0.00542	CcSEcCtD
Pramipexole—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00219	0.00541	CcSEcCtD
Pramipexole—DRD2—retina—type 1 diabetes mellitus	0.00219	0.0249	CbGeAlD
Pramipexole—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00215	0.0053	CcSEcCtD
Pramipexole—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00208	0.00513	CcSEcCtD
Pramipexole—Flushing—Ramipril—type 1 diabetes mellitus	0.00207	0.00511	CcSEcCtD
Pramipexole—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.00205	0.0233	CbGeAlD
Pramipexole—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00202	0.00497	CcSEcCtD
Pramipexole—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00201	0.00496	CcSEcCtD
Pramipexole—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.002	0.0228	CbGeAlD
Pramipexole—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.00198	0.0226	CbGeAlD
Pramipexole—Alopecia—Ramipril—type 1 diabetes mellitus	0.00197	0.00486	CcSEcCtD
Pramipexole—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00196	0.00482	CcSEcCtD
Pramipexole—Erythema—Ramipril—type 1 diabetes mellitus	0.00194	0.00479	CcSEcCtD
Pramipexole—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00194	0.00479	CcSEcCtD
Pramipexole—Tension—Ramipril—type 1 diabetes mellitus	0.00191	0.0047	CcSEcCtD
Pramipexole—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.0019	0.00469	CcSEcCtD
Pramipexole—Nervousness—Ramipril—type 1 diabetes mellitus	0.00189	0.00465	CcSEcCtD
Pramipexole—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00187	0.00461	CcSEcCtD
Pramipexole—Tremor—Ramipril—type 1 diabetes mellitus	0.00182	0.00449	CcSEcCtD
Pramipexole—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.0018	0.00445	CcSEcCtD
Pramipexole—Agitation—Ramipril—type 1 diabetes mellitus	0.00179	0.0044	CcSEcCtD
Pramipexole—ADRA2C—kidney—type 1 diabetes mellitus	0.00176	0.02	CbGeAlD
Pramipexole—Malaise—Ramipril—type 1 diabetes mellitus	0.00175	0.00432	CcSEcCtD
Pramipexole—ADRA2C—pancreas—type 1 diabetes mellitus	0.00175	0.0199	CbGeAlD
Pramipexole—Vertigo—Ramipril—type 1 diabetes mellitus	0.00175	0.0043	CcSEcCtD
Pramipexole—Syncope—Ramipril—type 1 diabetes mellitus	0.00174	0.0043	CcSEcCtD
Pramipexole—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00174	0.00429	CcSEcCtD
Pramipexole—Palpitations—Ramipril—type 1 diabetes mellitus	0.00172	0.00423	CcSEcCtD
Pramipexole—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00171	0.00421	CcSEcCtD
Pramipexole—Cough—Ramipril—type 1 diabetes mellitus	0.0017	0.00418	CcSEcCtD
Pramipexole—Convulsion—Ramipril—type 1 diabetes mellitus	0.00168	0.00415	CcSEcCtD
Pramipexole—Chest pain—Ramipril—type 1 diabetes mellitus	0.00165	0.00408	CcSEcCtD
Pramipexole—Myalgia—Ramipril—type 1 diabetes mellitus	0.00165	0.00408	CcSEcCtD
Pramipexole—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00165	0.00408	CcSEcCtD
Pramipexole—Anxiety—Ramipril—type 1 diabetes mellitus	0.00165	0.00407	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00164	0.00405	CcSEcCtD
Pramipexole—Discomfort—Ramipril—type 1 diabetes mellitus	0.00163	0.00403	CcSEcCtD
Pramipexole—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00162	0.00399	CcSEcCtD
Pramipexole—Confusional state—Ramipril—type 1 diabetes mellitus	0.0016	0.00394	CcSEcCtD
Pramipexole—Oedema—Ramipril—type 1 diabetes mellitus	0.00159	0.00391	CcSEcCtD
Pramipexole—Shock—Ramipril—type 1 diabetes mellitus	0.00156	0.00385	CcSEcCtD
Pramipexole—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00156	0.00383	CcSEcCtD
Pramipexole—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00155	0.00383	CcSEcCtD
Pramipexole—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00155	0.00382	CcSEcCtD
Pramipexole—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00154	0.0038	CcSEcCtD
Pramipexole—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00153	0.00378	CcSEcCtD
Pramipexole—Anorexia—Ramipril—type 1 diabetes mellitus	0.00151	0.00373	CcSEcCtD
Pramipexole—Hypotension—Ramipril—type 1 diabetes mellitus	0.00148	0.00365	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00145	0.00356	CcSEcCtD
Pramipexole—HTR2A—retina—type 1 diabetes mellitus	0.00144	0.0164	CbGeAlD
Pramipexole—Insomnia—Ramipril—type 1 diabetes mellitus	0.00143	0.00354	CcSEcCtD
Pramipexole—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00142	0.00351	CcSEcCtD
Pramipexole—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00141	0.00349	CcSEcCtD
Pramipexole—Somnolence—Ramipril—type 1 diabetes mellitus	0.00141	0.00348	CcSEcCtD
Pramipexole—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.0014	0.00344	CcSEcCtD
Pramipexole—ADRA2A—pancreas—type 1 diabetes mellitus	0.0014	0.0159	CbGeAlD
Pramipexole—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00138	0.0034	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00137	0.00338	CcSEcCtD
Pramipexole—Fatigue—Ramipril—type 1 diabetes mellitus	0.00137	0.00337	CcSEcCtD
Pramipexole—Constipation—Ramipril—type 1 diabetes mellitus	0.00136	0.00334	CcSEcCtD
Pramipexole—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00131	0.00322	CcSEcCtD
Pramipexole—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.0013	0.0032	CcSEcCtD
Pramipexole—Urticaria—Ramipril—type 1 diabetes mellitus	0.00126	0.00311	CcSEcCtD
Pramipexole—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00125	0.00309	CcSEcCtD
Pramipexole—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00125	0.00309	CcSEcCtD
Pramipexole—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.00122	0.0139	CbGeAlD
Pramipexole—HTR2A—kidney—type 1 diabetes mellitus	0.00119	0.0136	CbGeAlD
Pramipexole—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00117	0.00288	CcSEcCtD
Pramipexole—Asthenia—Ramipril—type 1 diabetes mellitus	0.00114	0.00281	CcSEcCtD
Pramipexole—Pruritus—Ramipril—type 1 diabetes mellitus	0.00112	0.00277	CcSEcCtD
Pramipexole—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00109	0.00268	CcSEcCtD
Pramipexole—Dizziness—Ramipril—type 1 diabetes mellitus	0.00105	0.00259	CcSEcCtD
Pramipexole—Vomiting—Ramipril—type 1 diabetes mellitus	0.00101	0.00249	CcSEcCtD
Pramipexole—Rash—Ramipril—type 1 diabetes mellitus	0.001	0.00247	CcSEcCtD
Pramipexole—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000999	0.00246	CcSEcCtD
Pramipexole—Headache—Ramipril—type 1 diabetes mellitus	0.000994	0.00245	CcSEcCtD
Pramipexole—Nausea—Ramipril—type 1 diabetes mellitus	0.000942	0.00232	CcSEcCtD
Pramipexole—DRD2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	5.36e-05	0.000106	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CD86—type 1 diabetes mellitus	5.36e-05	0.000106	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.35e-05	0.000106	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.34e-05	0.000106	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.34e-05	0.000105	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	5.28e-05	0.000104	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.26e-05	0.000104	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.26e-05	0.000104	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	5.22e-05	0.000103	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.22e-05	0.000103	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VAV1—type 1 diabetes mellitus	5.21e-05	0.000103	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.2e-05	0.000103	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	5.19e-05	0.000103	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.19e-05	0.000102	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CD86—type 1 diabetes mellitus	5.17e-05	0.000102	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.15e-05	0.000102	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CD86—type 1 diabetes mellitus	5.15e-05	0.000102	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	5.13e-05	0.000101	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	5.12e-05	0.000101	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	5.11e-05	0.000101	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.09e-05	0.0001	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CD80—type 1 diabetes mellitus	5.06e-05	9.99e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	5.05e-05	9.97e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CD86—type 1 diabetes mellitus	5.01e-05	9.88e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	4.99e-05	9.85e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CD80—type 1 diabetes mellitus	4.95e-05	9.78e-05	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.94e-05	9.76e-05	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.92e-05	9.71e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.91e-05	9.69e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.88e-05	9.64e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CD80—type 1 diabetes mellitus	4.87e-05	9.63e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.83e-05	9.54e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	4.8e-05	9.48e-05	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.78e-05	9.44e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—INS—type 1 diabetes mellitus	4.78e-05	9.44e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.75e-05	9.38e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.75e-05	9.38e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.73e-05	9.35e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.72e-05	9.31e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.68e-05	9.25e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—INS—type 1 diabetes mellitus	4.68e-05	9.24e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.66e-05	9.21e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.66e-05	9.21e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.66e-05	9.2e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CD80—type 1 diabetes mellitus	4.65e-05	9.19e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.65e-05	9.18e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.65e-05	9.18e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.65e-05	9.18e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.64e-05	9.16e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.64e-05	9.16e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL2—type 1 diabetes mellitus	4.64e-05	9.16e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.62e-05	9.13e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.62e-05	9.12e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—INS—type 1 diabetes mellitus	4.61e-05	9.1e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.6e-05	9.09e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.59e-05	9.06e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.56e-05	9.01e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	4.54e-05	8.97e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.53e-05	8.94e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.52e-05	8.93e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.51e-05	8.91e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.51e-05	8.9e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.5e-05	8.88e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.49e-05	8.86e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	4.47e-05	8.82e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.46e-05	8.82e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.46e-05	8.8e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.44e-05	8.77e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.43e-05	8.75e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—INS—type 1 diabetes mellitus	4.4e-05	8.68e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.39e-05	8.67e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.38e-05	8.64e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	4.34e-05	8.57e-05	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.34e-05	8.57e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CD80—type 1 diabetes mellitus	4.33e-05	8.55e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.31e-05	8.51e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.27e-05	8.43e-05	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	4.27e-05	8.43e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.25e-05	8.4e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—INS—type 1 diabetes mellitus	4.24e-05	8.38e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.24e-05	8.37e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.24e-05	8.37e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.23e-05	8.36e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.22e-05	8.34e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.19e-05	8.28e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.18e-05	8.26e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—INS—type 1 diabetes mellitus	4.15e-05	8.19e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	4.13e-05	8.15e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.12e-05	8.13e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.1e-05	8.11e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.1e-05	8.09e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—INS—type 1 diabetes mellitus	4.09e-05	8.08e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	4.07e-05	8.03e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.04e-05	7.98e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.03e-05	7.96e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.03e-05	7.95e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.01e-05	7.92e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.99e-05	7.88e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.97e-05	7.84e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.96e-05	7.83e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.96e-05	7.81e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—INS—type 1 diabetes mellitus	3.95e-05	7.81e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.94e-05	7.78e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.94e-05	7.78e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.93e-05	7.76e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	3.91e-05	7.72e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.91e-05	7.71e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.9e-05	7.71e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ALB—type 1 diabetes mellitus	3.89e-05	7.68e-05	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.88e-05	7.67e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.88e-05	7.66e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.86e-05	7.62e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.86e-05	7.61e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	3.78e-05	7.47e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.77e-05	7.45e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	3.75e-05	7.41e-05	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—NOS3—type 1 diabetes mellitus	3.72e-05	7.35e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.7e-05	7.32e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	3.69e-05	7.29e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.67e-05	7.24e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.66e-05	7.22e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	3.65e-05	7.21e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.64e-05	7.18e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ALB—type 1 diabetes mellitus	3.63e-05	7.16e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	3.62e-05	7.15e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.61e-05	7.12e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.59e-05	7.09e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.57e-05	7.06e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	3.57e-05	7.04e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.56e-05	7.03e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.56e-05	7.02e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	3.55e-05	7.02e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.55e-05	7.02e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.55e-05	7.01e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	3.55e-05	7.01e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.54e-05	6.98e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.53e-05	6.96e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.49e-05	6.88e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	3.48e-05	6.87e-05	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—NOS3—type 1 diabetes mellitus	3.47e-05	6.85e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.46e-05	6.84e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	3.45e-05	6.81e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.45e-05	6.81e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.43e-05	6.78e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.43e-05	6.78e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.43e-05	6.77e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	3.42e-05	6.76e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.41e-05	6.74e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.41e-05	6.73e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	3.35e-05	6.62e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.34e-05	6.59e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.32e-05	6.56e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	3.31e-05	6.54e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.3e-05	6.52e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.27e-05	6.46e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL2—type 1 diabetes mellitus	3.27e-05	6.45e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.26e-05	6.44e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.25e-05	6.42e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.24e-05	6.4e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.19e-05	6.29e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.17e-05	6.26e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	3.13e-05	6.18e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.13e-05	6.17e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.11e-05	6.14e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.09e-05	6.1e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.08e-05	6.09e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.08e-05	6.09e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	3.08e-05	6.08e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	3.07e-05	6.07e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.07e-05	6.06e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.05e-05	6.02e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	3.04e-05	6.01e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.03e-05	5.98e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.03e-05	5.98e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.03e-05	5.98e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	3.01e-05	5.95e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.99e-05	5.91e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.98e-05	5.88e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	2.97e-05	5.86e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.96e-05	5.85e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	2.94e-05	5.8e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.93e-05	5.78e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.88e-05	5.69e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	2.8e-05	5.53e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.8e-05	5.52e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.75e-05	5.43e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.75e-05	5.43e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.75e-05	5.43e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	2.75e-05	5.42e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.75e-05	5.42e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.73e-05	5.4e-05	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL6—type 1 diabetes mellitus	2.73e-05	5.39e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.72e-05	5.37e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.71e-05	5.35e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.7e-05	5.33e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.7e-05	5.33e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.66e-05	5.26e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.65e-05	5.24e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.65e-05	5.23e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.64e-05	5.22e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.64e-05	5.21e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	2.64e-05	5.21e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.62e-05	5.18e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.62e-05	5.17e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.59e-05	5.12e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.57e-05	5.07e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	2.57e-05	5.07e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.56e-05	5.05e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.55e-05	5.04e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.5e-05	4.94e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.5e-05	4.94e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.46e-05	4.85e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.36e-05	4.66e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.33e-05	4.6e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	2.33e-05	4.6e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.33e-05	4.59e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.32e-05	4.57e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.31e-05	4.56e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.29e-05	4.53e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.29e-05	4.52e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.28e-05	4.5e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.23e-05	4.4e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.22e-05	4.38e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.16e-05	4.26e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.1e-05	4.15e-05	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	2.09e-05	4.12e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.09e-05	4.12e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.08e-05	4.11e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.07e-05	4.09e-05	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.05e-05	4.04e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.03e-05	4e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.02e-05	3.98e-05	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	2.01e-05	3.97e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.96e-05	3.87e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.96e-05	3.87e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.93e-05	3.81e-05	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.92e-05	3.79e-05	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.81e-05	3.58e-05	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	1.79e-05	3.53e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.78e-05	3.51e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.75e-05	3.46e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.75e-05	3.46e-05	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	1.61e-05	3.19e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.59e-05	3.15e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.56e-05	3.08e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	1.55e-05	3.06e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	1.51e-05	2.98e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	1.37e-05	2.7e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.35e-05	2.66e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.22e-05	2.42e-05	CbGpPWpGaD
